World Biotechnology Congress

Dr. Suresh Kaushik is currently working as a Chief Technology Officer (Research) at the Indian Agricultural Research Institute, New Delhi, India. He received Ph.D. degree in the discipline of Molecular Biology and Biotechnology from National Research Center on Plant Biotechnology, Indian Agricultural Research Institute, New Delhi, India. His thesis research work included transgenic technology and field trials of genetically modified Bt Brinjal with cry1Ab and cry1B genes.

His current research work combines multidisciplinary approaches such as plant biotechnology, plant tissue culture, nanotechnology, soil microbiology and biochemistry, nutrients and heavy metals analysis using Inductively Coupled Plasma Mass Spectrometry. His other research interests include: food quality and food safety issues, nanotechnology and genomics in food science, green nanomaterials, smart intelligent nanofertilizers, elemental speciation analysis. He has published many book chapters and research papers on the topics related to nanotechnology and plant nutrients in enhancing agricultural crop productivity.

Ali karami is the Head of Biotechnology Research group, and Microarray department in Baqyiatallah University of Medical Sciences, Research Centre of Molecular Biology He completed PhD degree in , Molecular Biology University of Copenhagen, Denmark

His research area of interest includes Genetic Engineering, Molecular detection, Diagnosis, Recombinant protein, Recombinant Drugs and Vaccine, Bioinformatics, Biosafety, Biosecurity, Bioethics, Medical Biodefense

Waled Elkhoby is Professor in Rice research and training center, Agricultural Research Center, Egypt. He completed PhD degree in Agronomy, Tanta University, Egypt. His residual and international level research and training led to the scientific cooperation between his institute and National institute of Agrobiological sciences, Japan, Koipesol, Spain and Inversions Agro gourmet SAS, Colombia. He conducted research on the System of Rice Intensification (SRI) to minimize the quantities of water irrigation and chemical fertilizers which are used in cereal crops cultivation. He worked as head of (R&D), Olam international company. He also evaluated the international rice core collection under Egyptian conditions (heat, drought and salinity).

Agronomy, Plant nutrition, Water management, Plant physiology, Plant ecology and Seed production.

Alexander Seifalian, Professor of Nanotechnology and Regenerative Medicine worked at the Royal Free Hospital and University College London for over 26 years, during this time he spent a period of time at Harvard Medical School looking at caused of cardiovascular diseases and a year at Johns Hopkins Medical School looking at treatment of liver. He published more than 647 peer-reviewed research papers, and registered 14 UK and International patents. He is currently CEO of NanoRegMed Ltd, working on the commercialisation of his research. During his career Prof Seifalian has led and managed many large projects with successful outcomes in terms of commercialisation and translation to patients. In 2007 he was awarded the top prize in the field for the development of nanomaterials and technologies for cardiovascular implants by Medical Future Innovation, and in 2009 he received a Business Innovation Award from UK Trade & Investment (UKTI). He was the European Life Science Awards’ Winner of Most Innovative New Product 2012 for the “synthetic trachea”. Prof Seifalian won the Nanosmat Prize in 2013 and in 2016 he received the Distinguish Research Award in recognition of his outstanding work in regenerative medicine from Heals Healthy Life Extension Society. His achievements include development of the world first synthetic trachea, lacrimal drainage conduit, and vascular bypass graft using nanocomposite materials, bioactive molecules and stem cell technology. He has over 15,000 media report from his achievement, include BBC, ITV, WSJ, CNN, and many more.

Currently he is working on development and commercialisation of human organs using graphene based nanocomposite materials and stem cells technology.

Alexander Seifalian, Professor of Nanotechnology and Regenerative Medicine worked at the Royal Free Hospital and University College London for over 26 years, during this time he spent a period of time at Harvard Medical School looking at caused of cardiovascular diseases and a year at Johns Hopkins Medical School looking at treatment of liver. He published more than 647 peer-reviewed research papers, and registered 14 UK and International patents. He is currently CEO of NanoRegMed Ltd, working on the commercialisation of his research. During his career Prof Seifalian has led and managed many large projects with successful outcomes in terms of commercialisation and translation to patients. In 2007 he was awarded the top prize in the field for the development of nanomaterials and technologies for cardiovascular implants by Medical Future Innovation, and in 2009 he received a Business Innovation Award from UK Trade & Investment (UKTI). He was the European Life Science Awards’ Winner of Most Innovative New Product 2012 for the “synthetic trachea”. Prof Seifalian won the Nanosmat Prize in 2013 and in 2016 he received the Distinguish Research Award in recognition of his outstanding work in regenerative medicine from Heals Healthy Life Extension Society. His achievements include development of the world first synthetic trachea, lacrimal drainage conduit, and vascular bypass graft using nanocomposite materials, bioactive molecules and stem cell technology. He has over 15,000 media report from his achievement, include BBC, ITV, WSJ, CNN, and many more.

Currently he is working on development and commercialisation of human organs using graphene based nanocomposite materials and stem cells technology.

Experienced Vice President with a demonstrated history of working in the human resources industry. Skilled in Business Planning, Biomarkers, Sales, Medical Devices, and Oncology. Strong professional with a Doctor of Philosophy (Ph.D.) focused in Veterinary Clinical Studies from Faculty of Veterinary Medicine Kasetsart University.

Veterinary Medicine crop protection

Currently Working as a Chief Innovation Officer and Co-founder of Green Innovative Biotechnology ltd ,Experienced Vice President with a demonstrated history of working in the human resources industry. Skilled in Business Planning, Biomarkers, Sales, Medical Devices, and Oncology. Strong professional with a Doctor of Philosophy (Ph.D.) focused in Veterinary Clinical Studies from Faculty of Veterinary Medicine Kasetsart University.

Veterinary Medicine ,crop protection , Clinical Trials,Biopharmaceuticals,Oncology,Infectious Diseases,Drug Development.

Mr. Alejandro De la Parra is an entrepreneur focused on Information Technology, Education and Health. He is creative and results-driven and has 16+ years of Digital Strategy experience in architecture and implementation. Mr. De la Parra is the COO and Co-founding Partner at The Solomon Brokerage Firm. He currently leads as CEO at Mass Media Dynamics and De la Parra Mobile Solutions and is former CEO & Founder at Astrum Salud Móvil and its Telemedicine service Astrum Móvil. Moreover, he is COO & Co-founder at RegenerAge®Clinic & RegenerAge® Beauty, the Digital Strategy Director & Co-founder at Dr. Jois®, BiorganicAging®, What Skin Needs™ / WSN International Pty. Ltd. He also serves as current CMO at ReAnima Advanced Biosciences and is the Digital Media Director at Bioquark, Inc. He is also the former Latin America Region Manager and Digital Strategy adviser at CardiacSense. Within the academic and educational fields, Mr. De la Parra acts as the Executive Vice President of the Mobile Health Division, Chief Coordinating Officer, is a member of the Executive Council, the Education & Training Board (ETB), the Editorial Board, the Academy Faculty & is also a Senior Partner at WAMS, The World Academy of Medical Sciences. He also functions as COO and is a Co-founding Partner at The Reprogramming Medicine Association. Mr. De la Parra is also a member of the National Introducing Brokers Association and a part of the National Biofuel Board, (Alliance Program), founder and former Board of Directors member of Astrum Fundación, an advisor of the Lifeboat Foundation, advisor of the Future Worlds Center-Cyprus Neuroscience & Technology Institute (Senior TV Program), a Federated member of the International Longevity Alliance, advisor for Major Mouse Testing Program, member of the Web Committee at the Life Extension Advocacy Foundation/Lifespan.io and volunteered with SENS Research Foundation for the OncoSENS Program.

His research area of interest includes Regenerative Medicine, Reprogramming Medicine, Proteomics, Epigenetics, Mobile Health / Digital Health / eHealth, Telemedicine, HealthTech & Medical Technology, Artificial Intelligence Diagnostics & Drug Development, Biotechnology, Synthetic Biology, Bioethics, Continued Medical Education & e-Learning Platforms, Resilience & Governance Programs applied to Public Health & Health Education, Medical Negligence & Malpractice, Longevity Research, Spinal Cord Injury & Neuropathology, Neuroscience, Neuroregeneration, Neuroreanimation, and International Medicine.

Zeliha Selamoglu is a Professor in Medical Biology department of Nigde Ömer Halisdemir University, Turkey. She earned her PhD in Biology from Inonu University, She has published over 90 peerreviewed journal articles with over 800 citations and many technical reports. She is a member of Society for Experimental Biology and Medicine: Associate Membership and European association for cancer research. She has served as Editorial Board member for many Journals. h-index: 14 citations: 810

Medical Biology, Molecular Biology, Biochemistry, Biotechnology, Oxidative stress, Antioxidants, Cancer.

Dr. Manikant Tripathi Ph. D. (Microbiology), Dr. RML Avadh University, Faizabad (INDIA) Assistant Professor (Guest), Department of Microbiology, Dr. Ram Manohar Lohia Avadh University, Faizabad (INDIA) Ex-Assistant Professor, Jhunjhunwala PG College, Faizabad (INDIA) Email:manikant.microbio@gmail.com Mobile No.: +91-800-489-5080

Microbiology

Prof. Dr. Alireza Heidari, Ph.D., D.Sc. is a Full Professor and Academic Tenure of Chemistry at California South University (CSU), Irvine, California, USA. He has got his Ph.D. and D.Sc. degrees from California South University (CSU), Irvine, California, USA. Furthermore, he has double postdocs in Project Management, Oncology, Human Cancer Tissues and Synchrotron Radiation from Monash University, Melbourne, Victoria, Australia and also in Nanochemistry and Modern Molecular Electronic–Structure Computations Theory from California South University (CSU), Irvine, California, USA. His research interests include Biophysical Chemistry, Biomolecular Spectroscopy, Quantum Chemistry, Nanochemistry, Modern Electronic Structure Computations, Theoretical Chemistry, Mathematical Chemistry, Computational Chemistry, Vibrational Spectroscopy, Molecular Modelling, Ab initio & Density Functional Methods, Molecular Structure, Biochemistry, Molecular Simulation, Pharmaceutical Chemistry, Medicinal Chemistry, Oncology, Synchrotron Radiation, Synchrocyclotron Radiation, LASER, Anti–Cancer Nano Drugs, Nano Drugs Delivery, ATR–FTIR Spectroscopy, Raman Spectroscopy, Intelligent Molecules, Molecular Dynamics, Biosensors, Biomarkers, Molecular Diagnostics, Numerical Chemistry, Nucleic Acids, DNA/RNA Monitoring, DNA/RNA Hypermethylation & Hypomethylation, Human Cancer Tissues, Human Cancer Cells, Tumors, Cancer Tissues, Cancer Cells, etc. He has participated at more than three hundreds reputed international conferences, seminars, congresses, symposiums and forums around the world as yet. Also, he possesses many published articles in Science Citation Index (SCI)/International Scientific Indexing (ISI) Journals. It should be noted that he has visited many universities or scientific and academic research institutes in different countries such as United States, United Kingdom, Canada, Australia, Scotland, Ireland, Netherlands, Belgium, Denmark, Greece, Russia, Estonia, Turkey, France, Swiss, Germany, Sweden, Norway, Italy, Austria, Czech Republic, Hungary, Poland, South Africa, Egypt, Brazil, Spain, Portugal, Mexico, Japan, Singapore, Malaysia, Thailand, Taiwan, Hong Kong, South Korea, China, India, Qatar, United Arab Emirates, etc. as research fellow, sabbatical and volunteer researcher or visitor and so on heretofore. He has a history of several years of teaching for college students and various disciplines and trends in different universities. Moreover, he has been a senior advisor in various industry and factories. He is expert in many computer programs and programming languages. Hitherto, he has authored more than twenty books and book chapters in different fields of Chemistry. Syne, he has been awarded more than nine hundreds reputed international awards, prizes, scholarships and honors. Heretofore, he has multiple editorial duties in many reputed international journals, books and publishers. Hitherward, he is a member of more than three hundreds reputed international academic–scientific–research institutes around the world. It should be noted that he is currently the President of American International Standards Institute (AISI), Irvine, California, USA and also Director of the BioSpectroscopy Core Research Laboratory at California South University (CSU), Irvine, California

His research interests include Biophysical Chemistry, Biomolecular Spectroscopy, Quantum Chemistry, Nanochemistry, Modern Electronic Structure Computations, Theoretical Chemistry, Mathematical Chemistry, Computational Chemistry, Vibrational Spectroscopy, Molecular Modelling, Ab initio & Density Functional Methods, Molecular Structure, Biochemistry, Molecular Simulation, Pharmaceutical Chemistry, Medicinal Chemistry, Oncology, Synchrotron Radiation, LASER, Anti–Cancer Nano Drugs, Nano Drugs Delivery, ATR–FTIR Spectroscopy, Raman Spectroscopy, Intelligent Molecules, Molecular Dynamics, Biosensors, Biomarkers, Molecular Diagnostics, Numerical Chemistry, Nucleic Acids, DNA/RNA Monitoring, DNA/RNA Hypermethylation & Hypomethylation, Human Cancer Tissues, Human Cancer Cells, Tumors, Cancer Tissues, Cancer Cells, etc. A Bio–Spectroscopic Study of DNA Density and Color Role as Determining Factor for Absorbed Irradiation in Cancer Cells